(Q30852820)

English

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Christian von Plessen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Massimo Di Maio

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Mary E. R. O'Brien

4

object named as

Mary E R O'Brien

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Jong-Mu Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Fernando Barata

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Keunchil Park

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Bengt Bergman

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Barbara Parente

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ciro Gallo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Francesco Perrone

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Cesare Gridelli

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

14 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1254-1262

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal duration of first-line chemotherapy for advanced non-small cell lung cancer: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A note on quantifying follow-up in studies of failure time

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Exact and asymptotic tests for homogeneity in several 2 x 2 tables

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970402-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70402-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25232001%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30852820&oldid=2104617214"